These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 5121129)

  • 21. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
    Antonini F; Baroni A; Roveyaz L
    Sist Nerv; 1970; 22(2):74-81. PubMed ID: 5504560
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of parkinsonism with L-dopa].
    Chouza C; Marín C; Romero S; Gomensoro JB
    Acta Neurol Latinoam; 1970; 16(1):170-83. PubMed ID: 5538052
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of parkinsonism with L-dopa].
    Hernández Peniche J; Martínez Villar C; De León Charles C
    Rev Invest Clin; 1971; 23(2):125-32. PubMed ID: 5114336
    [No Abstract]   [Full Text] [Related]  

  • 24. [Parkinsonism and L-dopa: our 1st results].
    Warot P; Petit H; Chevalier-Lefebvre J; Herbaut G
    Lille Med; 1971 May; 16(5):765-7. PubMed ID: 5115349
    [No Abstract]   [Full Text] [Related]  

  • 25. [Preliminary results of the treatment with L-Dopa of 30 patients with Parkinsonism].
    Dumas R; Rahme M; Schott B
    J Med Lyon; 1971 Apr; 52(207):599-615. PubMed ID: 5136571
    [No Abstract]   [Full Text] [Related]  

  • 26. L-DOPA treatment for Parkinsonism: analysis of functional improvement.
    Jonas S
    Arch Phys Med Rehabil; 1971 Dec; 52(12):560-2. PubMed ID: 5136441
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of parkinsonism using a combination of L-dopa and decarboxylase inhibitor].
    Völler GW; Muschard F
    Med Welt; 1973 Apr; 24(17):705-7. PubMed ID: 4750934
    [No Abstract]   [Full Text] [Related]  

  • 28. [Attempt at treating parkinsonism with L-dopa and Artane].
    Stelmasiak Z; Lackowska H; Maksymowicz B
    Pol Tyg Lek; 1971 Aug; 26(34):1325-6. PubMed ID: 5110789
    [No Abstract]   [Full Text] [Related]  

  • 29. Preliminary observations on L-dopa in the treatment of Parkinson's disease.
    Jelsma F; Roth R; Ross P; Davis J
    J Ky Med Assoc; 1971 Apr; 69(4):265-9. PubMed ID: 5577419
    [No Abstract]   [Full Text] [Related]  

  • 30. Parkinsonism.
    Shimomura SK
    J Am Pharm Assoc; 1972 Jan; 12(1):29-36. PubMed ID: 4399879
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapy of parkinsonism with L-dopa].
    Völler GW; Deze J; Gundlach U
    Med Welt; 1970 Mar; 10():409-12. PubMed ID: 5436987
    [No Abstract]   [Full Text] [Related]  

  • 32. [L-DOPA therapy in patients with parkinsonism].
    Stam FC; Heslinga FJ
    Ned Tijdschr Geneeskd; 1970 May; 114(20):849-52. PubMed ID: 5446181
    [No Abstract]   [Full Text] [Related]  

  • 33. [The Rey complex picture test in evaluation of some effects induced by treatment with L-dopa in patients with parkinsonism].
    Megna GF; Puca FM; Micalizzi V; Leggiadro N; Di Rosa AE
    Acta Neurol (Napoli); 1971; 26(4):473-83. PubMed ID: 4943712
    [No Abstract]   [Full Text] [Related]  

  • 34. [The efficacy of the Umex treatment of parkinsonism patients in the initial stage of the disease].
    Fedorova NV; Glozman ZhM; Saltykova NM
    Ter Arkh; 1995; 67(10):75-7. PubMed ID: 8779116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [L-dopa in the treatment of parkinsonism].
    Goldsztajn M; Reichowa J
    Przegl Lek; 1971 Sep; 27(9):592-3. PubMed ID: 4942580
    [No Abstract]   [Full Text] [Related]  

  • 36. [L-dopa as a substitution for surgery in Parkinsonism?].
    Vladyka V
    Cesk Neurol Neurochir; 1973 Nov; 36(6):337-41. PubMed ID: 4769636
    [No Abstract]   [Full Text] [Related]  

  • 37. L-dopa: effect on highest integrative functions in Parkinsonism.
    Guthrie TC; Dunbar HS; Weider A
    Trans Am Neurol Assoc; 1970; 95():250-2. PubMed ID: 5514382
    [No Abstract]   [Full Text] [Related]  

  • 38. Quantitative analysis of the effects of L-dopa on gait in 26 patients with Parkinsonism.
    Peterson CR; Calvert JC; Canzoneri J; Leavitt LA; McCutchen JJ; Schwartz L
    Am J Phys Med; 1972 Aug; 51(4):171-81. PubMed ID: 5052844
    [No Abstract]   [Full Text] [Related]  

  • 39. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).
    Yahr MD; Duvoisin RC; Mendoza MR; Schear MJ; Barrett RE
    Trans Am Neurol Assoc; 1971; 96():55-8. PubMed ID: 5159129
    [No Abstract]   [Full Text] [Related]  

  • 40. L-dopa therapy in parkinsonism: mechanism of action.
    Sandler M
    Psychiatr Neurol Neurochir; 1971; 74(4):331-3. PubMed ID: 5146239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.